Augmented emicizumab-driven coagulation potential in hemophilia A state by in vitro and in vivo supplementation of combined factors IX and X

Combined FIX and FX supplementation could enhance coagulation potential in emicizumab-treated persons with HA and inhibitors.

Authors

Institutions

Publication Details

Journal
Research and Practice in Thrombosis and Haemostasis
Published
2025-12-30
DOI
https://doi.org/10.1016/j.rpth.2025.103329
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Augmented emicizumab-driven coagulation potential in hemophilia A state by in vitro and in vivo supplementation of combined factors IX and X

Keiji Nogami, Eisuke Takami, Yuto Nakajima, Mitsumasa Osuna et al.
Research and Practice in Thrombosis and Haemostasis
Hemophilia Treatment and Research
article

Augmented emicizumab-driven coagulation potential in hemophilia A state by in vitro and in vivo supplementation of combined factors IX and X

Keiji Nogami, Eisuke Takami, Yuto Nakajima, Mitsumasa Osuna, Hirotoshi Nakano
article en

Abstract

Combined FIX and FX supplementation could enhance coagulation potential in emicizumab-treated persons with HA and inhibitors.

Research and Practice in Thrombosis and HaemostasisVol. 10(1)
KM Biologics (Japan) (JP), Nara Medical University (JP)
Zero hunger
Openalex Percentile: Top 24%
Hemophilia Treatment and Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.